Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ingram

Showing results (381-390 of 442) with videos related to

Pageof 45
Sort By:
The Oncologist|October 10, 2022
Physician Perspectives on Reducing Curative Cancer Treatment Intensity for Populations Underrepresented in Clinical TrialsGabrielle B Rocque, Courtney Andrews, Valerie M Lawhon, et al.
Experimental Hematology|June 26, 2007
Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitorsJamie Case, Laura E Mead, Waylan K Bessler, et al.
Cancer|October 27, 2020
Quantifying treatment preferences and their association with financial toxicity in women with breast cancerCourtney P Williams, Kathleen D Gallagher, Katie Deehr, et al.
Human Molecular Genetics|April 29, 2006
Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cellsFang Li, Amy M Munchhof, Hilary A White, et al.
Free Radical Biology & Medicine|June 9, 2016
Neurofibromin is a novel regulator of Ras-induced reactive oxygen species production in mice and humansWaylan K Bessler, Farlyn Z Hudson, Hanfang Zhang, et al.
American Journal of Respiratory and Critical Care Medicine|March 2, 2017
Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm InfantsLindsey A Morrow, Brandie D Wagner, David A Ingram, et al.
JCO Oncology Practice|December 6, 2022
Oncologist-Reported Barriers and Facilitators to Enrolling Patients in Optimization Trials That Test Less Intense Cancer TreatmentGabrielle B Rocque, Courtney Andrews, Valerie M Lawhon, et al.
The Oncologist|August 19, 2018
Impact of Guideline-Discordant Treatment on Cost and Health Care Utilization in Older Adults with Early-Stage Breast CancerCourtney P Williams, Kelly M Kenzik, Andres Azuero, et al.
Journal of Exposure Science & Environmental Epidemiology|November 14, 2022
Sanitary sewage overflows, boil water advisories, and emergency room and urgent care visits for gastrointestinal illness: a case-crossover study in South Carolina, USA, 2013-2017Sarah E Rothenberg, Jessica M Furrer, Lucy A Ingram, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 17, 2009
Bone marrow-derived angiogenic cells restore lung alveolar and vascular structure after neonatal hyperoxia in infant miceVivek Balasubramaniam, Sharon L Ryan, Gregory J Seedorf, et al.
Pageof 45

Showing results (381-390 of 442) with videos related to

Sort By:
Pageof 45
The Oncologist|October 10, 2022
Physician Perspectives on Reducing Curative Cancer Treatment Intensity for Populations Underrepresented in Clinical TrialsGabrielle B Rocque, Courtney Andrews, Valerie M Lawhon, et al.
Experimental Hematology|June 26, 2007
Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitorsJamie Case, Laura E Mead, Waylan K Bessler, et al.
Cancer|October 27, 2020
Quantifying treatment preferences and their association with financial toxicity in women with breast cancerCourtney P Williams, Kathleen D Gallagher, Katie Deehr, et al.
Human Molecular Genetics|April 29, 2006
Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cellsFang Li, Amy M Munchhof, Hilary A White, et al.
Free Radical Biology & Medicine|June 9, 2016
Neurofibromin is a novel regulator of Ras-induced reactive oxygen species production in mice and humansWaylan K Bessler, Farlyn Z Hudson, Hanfang Zhang, et al.
American Journal of Respiratory and Critical Care Medicine|March 2, 2017
Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm InfantsLindsey A Morrow, Brandie D Wagner, David A Ingram, et al.
JCO Oncology Practice|December 6, 2022
Oncologist-Reported Barriers and Facilitators to Enrolling Patients in Optimization Trials That Test Less Intense Cancer TreatmentGabrielle B Rocque, Courtney Andrews, Valerie M Lawhon, et al.
The Oncologist|August 19, 2018
Impact of Guideline-Discordant Treatment on Cost and Health Care Utilization in Older Adults with Early-Stage Breast CancerCourtney P Williams, Kelly M Kenzik, Andres Azuero, et al.
Journal of Exposure Science & Environmental Epidemiology|November 14, 2022
Sanitary sewage overflows, boil water advisories, and emergency room and urgent care visits for gastrointestinal illness: a case-crossover study in South Carolina, USA, 2013-2017Sarah E Rothenberg, Jessica M Furrer, Lucy A Ingram, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 17, 2009
Bone marrow-derived angiogenic cells restore lung alveolar and vascular structure after neonatal hyperoxia in infant miceVivek Balasubramaniam, Sharon L Ryan, Gregory J Seedorf, et al.
Pageof 45